Sst. To et al., REGULATION OF ADHESION MOLECULE EXPRESSION BY HUMAN SYNOVIAL MICROVASCULAR ENDOTHELIAL-CELLS IN-VITRO, Arthritis and rheumatism, 39(3), 1996, pp. 467-477
Objective. To examine the in vitro expression of E-selectin, P-selecti
n, intercellular adhesion molecule 1 (ICAM-1), ICAM-2, vascular cell a
dhesion molecule 1 (VCAM-1), and platelet-endothelial cell adhesion mo
lecule 1 (PECAM-1) by synovial microvascular endothelial cells (SMEC)
in comparison with microvascular neonatal foreskin endothelial cells (
FSE) and macrovascular human umbilical vein endothelial cells (HUVE).
Methods. Cultured endothelial cells were treated for 4 hours with medi
um alone or tumor necrosis factor alpha (TNF alpha). The expression of
endothelial adhesion molecules was evaluated by how cytometry, cell e
nzyme-linked immunosorbent assay, and Northern blot analysis. Results.
SMEC continuously expressed E-selectin under basal culture conditions
, whereas FSE and HUVE did not, TNF alpha treatment of rheumatoid arth
ritis (RA) SMEC resulted in sustained peak expression of E-selectin fo
r up to 24 hours, which subsequently declined but remained elevated ev
en at 72 hours. In contrast, peak E-selectin expression in FSE and HUV
E occurred between 4 hours and 16 hours after TNF alpha treatment and
then declined to near basal levels by 24-48 hours. SMEC expressed sign
ificantly higher levels of ICAM-1 compared with HUVE under basal cultu
re conditions. There was no difference between SMEC, FSE, and HUVE in
the expression of P-selectin, VCAM-1, ICAM-2, or PECAM-1. Northern blo
t analysis demonstrated that the levels of E-selectin expression by TN
F alpha-stimulated endothelial cells correlated with their respective
messenger RNA levels. Conclusion. Regulation of E-selectin and ICAM-1
expression in RA synovial endothelium is different from that in neonat
al foreskin and human umbilical vein endothelium. The augmented expres
sion of adhesion molecules in RA synovial endothelium may facilitate t
he recruitment of leukocytes to this site.